Skip to main content
Premium Trial:

Request an Annual Quote

Allen Ruzycki, Christopher Yoo, Merrilyn Datta, Charles Ma, George Jokhadze, and Judith Swain

Premium

Phyton Biotech, a subsidiary of Fort Worth, Texas-based DFB Pharmaceuticals, said last week that Allen Ruzycki has joined the company as director of finance and administration.

Ruzycki was most recently acting director of finance for an unnamed privately held company, Phyton said. He has also been employed by Nabisco, Fisher Scientific, Poly Chrome, and BASF Corporation. Ruzycki holds a BA in finance from Drexel University and an MBA in finance from Fairleigh Dickinson University.


Christopher Yoo has joined Applied Biosystems as worldwide director of marketing for ABI’s molecular biology division, the company said last month. Yoo was previously head of strategy for IBM’s Information Based Medicine business unit.


Invitrogen has appointed Merrilyn Datta as the company’s new director of RNAi in the functional genomics business segment. Datta replaces Nikki Zahl, who has become director of genomics at Invitrogen.

In her new position, Datta is in charge of all of Invitrogen’s business initiative related to RNAi, the company said. She was previously marketing manager for RNAi at the company, and before that marketing manager for cloning and gene expression.

Datta holds a PhD from Harvard University, and a BS from Emory University.


Charles Ma has become chief scientist of Phalanx Biotech Group, and George Jokhadze director of operations of PhalanxBio, the group’s US subsidiary, the Taiwan-based microarray company said last month. Jokhadze was previously a senior research scientist and group leader at BD Clontech, where he co-developed microarrays. He holds a PhD in molecular biology from the Academy of Sciences in Russia. Ma has been an associate research scientist at Columbia University since 1995. He holds a PhD in molecular biology from the University of California, Los Angeles.


Judith Swain, chairman of the department of medicine at Stanford University, has been named the first director of the College of Integrated Life Sciences at the University of California, San Diego, the school announced recently. She will head a new multidisciplinary program that is based within the university’s health sciences department and is designed to facilitate translational research, and the training of physicians, pharmacists, and medical researchers.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.